The AP-1 site and MMP gene regulation: What is all the fuss about?

Matrix Biology

Volumn 15, Issue 8-9, 1997, Pages 519-526

  Benbow, Ulrike ^a   Brinckerhoff, Constance E ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Cytokines; Extracellular matrix; Growth factors; Matrix metalloproteinase; PEA3; Transcription

Indexed keywords

CIS ACTING ELEMENT; CYTOKINE; GLUCOCORTICOID; GROWTH FACTOR; MATRIX METALLOPROTEINASE; PHORBOL 13 ACETATE 12 MYRISTATE; RETINOID; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL SPECIFICITY; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE REPRESSION; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; TISSUE SPECIFICITY; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0030932125     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(97)90026-3     Document Type: Short Survey

References (60)

1. Angel P., Baumann I., Stein B., Delius H., Rahmsdorf H.J., Herrlich P. 12-O-Tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol. Cell Biol. 7:1987;2256-2266.
2. Auble D.T., Brinckerhoff C.E. The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase in fibroblasts. Biochemistry. 30:1991;4629-4635.
3. Ballock R.T., Heydemann A., Wakefield L.M., Flanders K.C., Roberts A.B., Sporn M.B. Inhibition of the chondrocyte phenotype by retinoic acid involves upregulation of metalloprotease genes independent of TGF-β J. Cell Physiol. 159:1994;340-346.
4. Bassuk A.G., Leiden J.M. A direct physical association between ETS and AP-1 transcription factors in normal human T cells. Immunity. 3:1995;223-237.
5. Belaaouaj A., Shipley J.M., Kobayashi D.K., Zimonjic D.B., Popescu N., Silverman G.A., Shapiro S.D. Human macrophage metalloelastase. Genomic organization, chromosomal location, gene linkage, and tissue-specific expression. J. Biol. Chem. 270:1995;14568-14575.
6. Birkedal-Hansen H., Moore W.G., Bodden M.K., Windsor L.J., Birkedal-Hansen B., DeCarlo A., Engler J.A. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4:1993;197-250.
7. Brenner D.A., O'Hara M., Angel P., Chojkier M., Karin M. Prolonged activation of jun and collagenase genes by tumor necrosis factor-α Nature. 337:1989;661-663.
8. Buttice G., Kurkinen M. A polymavirus enhancer A-binding protein-3 site and Ets-2 protein have a major role in the 12-O-tetradecanoylphorbol-13-acetate response fo the human stromelysin gene. J. Biol. Chem. 268:1993;7196-7204.
9. Buttice G., Quinones S., Kurkinen M. The AP-1 site is required for basal expression but is not necessary for TPA-response of the human stromelysin gene. Nucleic Acids Res. 19:1991;3723-3731.
10. Chamberlain S.H., Hemmer R.M., Brickerhoff C.E. Novel phorbol ester response region in the collagenase promoter binds Fos and Jun. J. Cell Biochem. 52:1993;337-351.
11. Conca W, Kaplan P.B., Krane S.M. Increases in levels of procollagenase mRNA in human fibroblasts induced by interleukin-1, tumor necrosis factor-alpha, or serum follow c-jun expression are dependent on new protein synthesis. Trans. Asso. Am. Physicians. 102:1989;195-203.
12. Crawford H.C., Matrisian L.M. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis. 14:1994;234-245.
13. Deng T., Karin M. JunB differs from c-Jun in its DNA-binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers. Genes. Dev. 7:1993;479-490.
14. Fini M.E., Bartlett J.D., Matsubara M., Rinehart W.B., Mody M.K., Girard M.T., Rainville M. The rabbit gene for 92-kDa matrix metalloproteinase. Role of AP1 and AP2 in cell type-specific transcription. J. Biol. Chem. 269:1994;28620-28628.
15. Frisch S.M., Morisaki J.H. Positive and negative transcriptional elements of the human type IV collagenase gene. Mol. Cell Biol. 10:1990;6524-6532.
16. Gaire M., Magbanua Z., McDonnell S., McNeil L., Lovett D.H., Matrisian L.M. Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J. Biol. Chem. 269:1994;2032-2040.
17. Gum R., Lengyel E., Juarez J., Chen J.H., Sato H., Seiki M., Boyd D. Stimulation of 92-kDa gelatine B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J. Biol. Chem. 271:1996;10672-10680.
18. Gutman A., Wasylyk B. The collagenase gene promoter contains a TPA oncogne-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO. 9:1990;2241-2246.
19. Haraoui B., Wilder R.L., Allen J.B., Sporn M.B., Helfgott R.K., Brinckerhoff C.E. Dose-dependent suppression by the synthetic retinoid 4-hydroxyphenyl retinamide of streptococcal cell wall-induced arthritis in rats. Int. J. Immunopharmacol. 7:1985;903-916.
20. Imai S., Fujino T., Nishibayashi S., Manabe T., Takano T. Immortalization-susceptible elements and their binding factors mediate rejuvenation of regulation of the type I collagenase gene in simian virus 40 large T antigen-transformed immortal human fibroblasts. Mol. Cell Biol. 14:1994;7182-7194.
21. James T.W., Wagner R., White L.A., Zwolak R.M., Brinckerhoff C.E. Induction of collagenase and stromelysin gene expression by mechanical injury in a vascular smooth muscle-derived cell line. J. Cell Physiol. 157:1993;426-437.
22. Jonat C., Rahmsdorf H.J., Park K.K., Cato A.C., Gebel S., Ponta H., Herrlich P. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/ Jun) activity by glucocorticoid hormone. Cell. 62:1990;1189-1204.
23. Kerr L.D., Miller D.B., Matrisian L.M. TGF-beta 1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence. Cell. 61:1990;267-267.
24. Kirstein M., Sanz L., Quinones S., Moscat J., Diaz-Meco M.T., Saus J. Cross-talk between different enhancer elements during mitogenic induction of the human stromelysin-1 gene. J. Biol. Chem. 271:1996;18231-18236.
25. Konig H., Ponta H., Rahmsdorf H.J., Herrlich P. Cell-type specific multiprotein complex formation over the c-fos serum response element in vivo: ternary complex formation is not required for the induction of c-fos. Nucleic Acids Res. 19:1991;3607-3611.
26. Kramer I.M., Koornneef I., de Laat S.W., van den Eijndenvan Raaij A.J. TGF-beta 1 induces phosphorylation of the cyclic AMP responsive element binding protein in ML-CC164 cells. Embo J. 10:1991;1083-1089.
27. Lafyatis R., Kim S.J., Angel P., Roberts A.B., Sporn M.B., Karin M., Wilder R.L. Interleukin-1 stimulates and all-trans-retinoic acid inhibits collagenase gene expression through its 5′ activator protein-1-binding site. Mol. Endocrinol. 4:1990;973-980.
28. Leask A., Byrne C., Fuchs E. Transcription factor AP2 and its role in epidermal-specific gene expression. Proc. Natl. Acad. Sci. USA. 88:1991;7948-7952.
29. Lin C.W., Robbins P.D., Georgescu H.I., Evans C.H. Effects of immortalization upon the induction of matrix metalloproteinases in rabbit synovial fibroblasts. Exp. Cell Res. 223:1996;117-126.
30. MacNaul K.L., Chartrain N., Lark M., Tocci M.J., Hutchinson N.I. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblats. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J. Biol. Chem. 265:1990;17238-17245.
31. Mangelsdorf D.J., Umesono K., Evans R.M. The retinoid receptors. Sporn M.B., Roberts A.B., Goodman D.S. The retinoids: biology, chemistry and medicine. 1994;319-349 Raven Press, New York.
32. Martin M.L., Lieberman P.L., Curran L. Fos-jun Dimerization promoter Interaction of the Basic Region with TFIIF-34 and TFIIF. Mol. Cell. Biol. 16:1996;2110-2118.
33. Matrisian L.M. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 6:1990;121-125.
34. Mauviel A., Chung K.Y., Agarwal A., Tamai K., Uitto J. Cell-specific induction of distinct oncogenes of the Jun family is responsible for differential regulation of collagenase gene expression by transforming growth factor-beta in fibroblasts and keratinocytes. J. Biol. Chem. 271:1996;10917-10923.
35. Mauviel A., Halcin C., Vasiloudes P., Parks W.C., Kurkinen M., Uitto J. Uncoordinate regulation of collagenase, stromelysin, and tissue inhibitor of metalloproteinases genes by prostaglandin E2: selective enhancement of collagenase gene expression in human dermal fibroblasts in culture. J. Cell Biochem. 54:1994;465-472.
36. Nagase H. Hooper N.M. Zinc metalloprotease in health and disease. 1996;153-204 Taylor and Francis, London.
37. Nakabeppu Y., Ryder K., Nathans D. DNA binding activities of three murine Jun proteins. Stimulation by Fos. Cell. 55:1988;907-915.
38. Nerlov C., Rorth P., Blasi E., Johnsen M. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene. 6:1991;1583-1592.
39. Nicholson R.C., Mader S., Nagpal S., Leid M., Rochette-Egly C., Chambon P. Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an API binding site. Embo J. 9:1990;4443-4454.
40. Pan L., Chamberlain S.H., Auble D.T., Brinckerhoff C.E. Differential regulation of collagenase gene expression by retinoic acid receptors alpha, beta and gamma. Nucleic Acids Res. 20:1992;3105-3111.
41. Pan L., Eckhoff C., Brinckerhoff C.E. Suppression of collagenase gene expression by all-trans and 9-cis retinoic acid is ligand dependent and requires both RARs and RXRs. J. Cell Biochem. 57:1995;575-589.
42. Pfahl M. Nuclear receptor/AP-1 interaction. Endocr. Rev. 14:1993;651-658.
43. Risse G., Jooss K., Neuberg M., Bruller H.J., Muller R. Asymmetrical recognition of the palindromic API binding site (TRE) by Fos protein complexes. Embo J. 8:1989;3825-3832.
44. Saarialho-Kere U.K., Pentland A.P., Birkedal-Hansen H., Parks W.C., Welgus H.G. Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J. Clin. Invest. 94:1994;79-88.
45. Sanz L., Moscat J., Diaz-Meco M.T. Molecular characterization of a novel transcription factor that control stromelysin expression. Mol. Cell Biol. 15:1995;3164-3170.
46. Sato H., Kita M., Seiki M. v-Src activities the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. J. Biol. Chem. 268:1993;23460-23468.
47. Sato H., Seiki M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene. 8:1993;395-405.
48. Schroen D.J., Brinckerhoff C.E. Inhibition of rabbit collagenase (Matrix metalloproteinase-1; MMP-1) transcription by retinoid receptors: Evidence for binding of RARs/RXRs to the - 77 AP-1 site through interactions with c-Jun. J. Cell Physiol. 169:1996;321-332.
49. Schroen D.J., Brinckerhoff C.E. Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through divers mechanisms. Gene Expression. 1997;. in press.
50. Schule R., Rangarajan P., Yang N., Kliewer S., Ransone L.J., Bolado J., Verman I.M., Evans R.M. Retinoic acid is an negative regulator of AP-1 responsive genes. Proc. Natl. Acad. Sci. USA. 88:1991;6092-6096.
51. Sreenath T., Matrisian L.M., Stetler-Stevenson W., Gattoni-Celli S., Pozzatti R.O. Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential. Cancer Res. 52:1992;4942-4947.
52. Templeton N.S., Stetler-Stevenson W.G. Identification of a basal promoter for the human Mr 72,000 type IV collagenase gene and enhanced expression in a highly metastatic cell line. Cancer Res. 51:1991;6190-6193.
53. Vincenti M.P., Clark I.M., Brinckerhoff C.E. Using inhibitors of metalloproteinases to treat arthritis. Easier said than done? Arthritis Rheum. 37:1994;1115-1126.
54. Vincenti M.P., Coon C.L., Lee O., Brinckerhoff C.E. Regulation of collagenase gene expression by IL-1 beta requires transcriptional and post-transcripitonal mechanisms. Nucleic Acids Res. 22:1994;4818-4827.
55. Wasylyk B., Wasylyk C., Flores P., Bengue A., Leprince D., Stehelin D. The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation. Nature. 346:1990;191-193.
56. Wasylyk C., Gutman A., Nicholson R., Wasylyk B. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. Embo J. 10:1991;1127-1134.
57. White L.A., Brinckerhoff C.E. Two AP-1 clements in the collagenase (MMP-1) promoter have differential effects on transcription and bind JunD, c-Fos, and Fra-2. Matrix Biol. 14:1995;715-725.
58. Windsor L.J., Grenett H., Birkedal-Hansen B., Bodden M.K., Engler J.A., Birkedal-Hansen H. Cell type-specific regulation of SL-1 and SL-2 genes. Induction of the SL-2 gene but not the SL-1 gene by human keratinocytes in response to cytokines and phorbolesters. J. Biol. Chem. 268:1993;17341-17347.
59. Woessner J.F. Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5:1991;2145-2154.
60. Yang M., Kurkinen M. Different mechanisms of regulation of the human stromelysin and collagenase genes. Analysis by a reverse-transcription coupled-PCR assay. Eur. J. Biochem. 222:1994;651-658.